Mapping Oncological Therapies with MALDI MSI Technology
22 Apr 2019
In this video, discover how the spatial distribution of oncological therapies can be characterized using matrix-assisted laser desorption/ionization mass spectrometric imaging (MALDI MSI) technology. Using the mimetic model protocol and the MALDI SYNAPT G2-Si high definition mass spectrometer from Waters Corporation, Dr. Bindesh Shrestha demonstrates the semi-quantification of the chemotherapy drug, doxorubicin.
This interview was filmed as part of our coverage of AACR 2019 - see other video highlights here >>
Related Products
Request Quote for All Products
MALDI SYNAPT G2-Si High Definition Mass Spectrometry
WatersRedefining Resolution - Resolution in 3 Dimensions. MALDI SYNAPT G2-Si is a uniquely powerful and versatile MS platform. It's the only way to combine multiple dimensions of separation for analysis of complex samples, from imaging to biological research to chemical materials characterization. The MALDI SYNAPT G2-Si gives you high performance, accurate mass MALDI MS/MS, superior post-ionization separation with T-Wave IMS, High Definition Imaging (HDI) MALDI workflows, versatile experimental options, and the ultimate UPLC/MS/MS performance.
